Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Modern Dental GroupFRA:1MD -0.62%85 3-Year ROIIC % is 50.49 as of Dec. 2025, which is at its 10-year median of 50.49. GuruFocus rates FRA:1MD with a GF Score™ of 85/100 and a GF Value™ of €0.55 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Modern Dental Group ranks better than 83.14% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Modern Dental Group's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 50.49%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Modern Dental Group's 3-Year ROIIC % or its related term are showing as below:
FRA:1MD's 3-Year ROIIC % is ranked better than 83.14% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs FRA:1MD: 50.49
Modern Dental Group (FRA:1MD) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Modern Dental Group 3-Year ROIIC % Related Terms
Modern Dental Group 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Modern Dental Group's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1MD vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Modern Dental Group's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modern Dental Group 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Modern Dental Group's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Modern Dental Group's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Modern Dental Group (FRA:1MD) has a 3-Year ROIIC % of 50.49 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Modern Dental Group and its competitors. This is near median its historical median of 50.49. Over the past decade, Modern Dental Group's 3-Year ROIIC % has ranged from 0.95 to 275.19. According to the industry distribution chart, Modern Dental Group ranks #134 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 16.9%.
Is Modern Dental Group's 3-Year ROIIC % too high?
Modern Dental Group's current 3-Year ROIIC % of 50.49 is near median its 10-year median of 50.49. Over the past 10 years, this metric has ranged from a low of 0.95 to a high of 275.19. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.47. Modern Dental Group's value of 50.49 is 3334.7% above this industry median. Based on the distribution chart, Modern Dental Group ranks #134 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Modern Dental Group has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Modern Dental Group's 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Modern Dental Group ranks #134 out of 795 companies for 3-Year ROIIC %. This places Modern Dental Group in the top 17% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.47. Modern Dental Group's value of 50.49 is 3334.7% above this benchmark. Historically, Modern Dental Group's own 3-Year ROIIC % has ranged from 0.95 to 275.19 over the past decade. While the company's 10-year median is 50.49 vs. the industry median of 1.47, Modern Dental Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Modern Dental Group's current 3-Year ROIIC % of 50.49 is 3334.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Modern Dental Group and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modern Dental Group's current 3-Year ROIIC % is 50.49, which is near median its own 10-year median of 50.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Dental Group stock overvalued right now?
Based on GuruFocus' analysis, Modern Dental Group (FRA:1MD) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.55, compared to a current price of €0.80 — trading 44.5% above its estimated fair value. The current 3-Year ROIIC % is 50.49, which is near median its 10-year median of 50.49 and 3334.7% above the Medical Devices & Instruments industry median of 1.47. Modern Dental Group's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Modern Dental Group (FRA:1MD), the current 3-Year ROIIC % is 50.49 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Modern Dental Group (FRA:1MD) Overvalued in 2026?
Based on GuruFocus' analysis, Modern Dental Group stock appears to be overvalued.
The current stock price of €0.80 is trading 44.5% above its estimated GF Value™ of €0.55.
GuruFocus considers Modern Dental Group to be Significantly Overvalued.
Key valuation signals for FRA:1MD:
3-Year ROIIC %: 50.49 (near median its 10-year median of 50.49)
GF Value™: €0.55 vs. price of €0.80 (44.5% above fair value)
Industry Position: 3334.7% above the Medical Devices & Instruments median (#134 of 795)
No single metric tells the full story. See the FRA:1MD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Modern Dental Group Ltd, along with its subsidiaries, is engaged in providing dental prosthetic devices. Its product portfolio is categorized into three segments: the Fixed prosthetic devices segment is a supplier of restorative dental procedures, such as crowns, bridge and implants; the Removable prosthetic devices segment produces full dentures and partial dentures; and Other devices such as orthodontic devices, sport guards and anti-snoring devices, raw materials, dental equipment (including intra-oral scanners), the service of educational events and seminars rendered. It generates the majority of its revenue from the sale of Fixed prosthetic devices. Its geographical segments are Europe, which derives key revenue, North America, Australia, Greater China, and other countries.
85GF Score
Get the complete analysis for FRA:1MD
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1MD has been successfully added to your 
